Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Daniela A Terribile"'
Autor:
Luisa Carbognin, Cristina Accetta, Danilo Di Giorgio, Paola Fuso, Margherita Muratore, Giordana Tiberi, Francesco Pavese, Tatiana D’Angelo, Alessandra Fabi, Diana Giannarelli, Alba Di Leone, Stefano Magno, Giorgia Garganese, Alejandro Martin Sanchez, Daniela Andreina Terribile, Gianluca Franceschini, Riccardo Masetti, Giovanni Scambia, Ida Paris
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7218-7228 (2022)
The prevention of chemotherapy-induced alopecia still represents an urgent need for every day clinical practice. In this regard, this prospective single-center study included breast cancer (BC) patients who underwent a scalp cooling device (Dignicap
Externí odkaz:
https://doaj.org/article/94ed6c69ae5040409e2ad6a4962e5438
Autor:
Francesco Cognetti, Riccardo Masetti, Alessandra Fabi, Giulia Bianchi, Donatella Santini, Alessia Rognone, Giovanna Catania, Domenico Angelucci, Giuseppe Naso, Mario Giuliano, Lucia Vassalli, Patrizia Vici, Giovanni Scognamiglio, Daniele Generali, Alberto Zambelli, Marco Colleoni, Corrado Tinterri, Francesco Scanzi, Leonardo Vigna, Paola Scavina, Teresa Gamucci, Emilia Marrazzo, Angelo Fedele Scinto, Rossana Berardi, Maria Agnese Fabbri, Graziella Pinotti, Daniela Franco, Daniela Andreina Terribile, Giuseppe Tonini, Daniela Cianniello, Sandro Barni
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Clinicopathological prognostic features have limited value to identify with precision newly diagnosed patients with hormone receptor (HR)-positive, HER2-negative breast cancer (BC), who would benefit from chemotherapy (CT) in addition to adj
Externí odkaz:
https://doaj.org/article/a0a882fd09a64018b374c4f2f70cd885
Autor:
Andreina Oliverio, Paolo Radice, Mara Colombo, Angelo Paradiso, Stefania Tommasi, Antonella Daniele, Daniela Andreina Terribile, Stefano Magno, Donatella Guarino, Siranoush Manoukian, Bernard Peissel, Eleonora Bruno, Patrizia Pasanisi
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
The female carriers of BRCA1/2 pathogenic variants (mutations) face a high lifetime risk of developing breast and/or ovarian cancer. However, the risk may differ depending on various genetic and non-genetic elements, including metabolic and hormonal
Externí odkaz:
https://doaj.org/article/6b7f272113cf49349aa61b307a767449
Autor:
Antonio Franco, Alba Di Leone, Alessandra Fabi, Paolo Belli, Luisa Carbognin, Elisabetta Gambaro, Fabio Marazzi, Elena Jane Mason, Antonino Mulè, Armando Orlandi, Antonella Palazzo, Ida Paris, Alessandro Rossi, Lorenzo Scardina, Daniela Andreina Terribile, Giordana Tiberi, Diana Giannarelli, Giovanni Scambia, Riccardo Masetti, Gianluca Franceschini
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2450
Background: The diffusion of screening programs has resulted in a decrease of cT4 breast cancer diagnosis. The standard care for cT4 was neoadjuvant chemotherapy (NA), surgery, and locoregional or adjuvant systemic therapies. NA allows two outcomes:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30144e606f04a0d98f86890daa697343
Autor:
Giacomo Montagna, Robin Schaffar, Andrea Bordoni, Alessandra Spitale, Daniela A. Terribile, Lorenzo Rossi, Yvan Bergeron, Bernadette W. A. van der Linden, Isabelle Konzelmann, Sabine Rohrmann, Katharina Staehelin, Manuela Maspoli-Conconi, Jean-Luc Bulliard, Francesco Meani, Olivia Pagani, Elisabetta Rapiti
Publikováno v:
Cancers, vol. 14, no. 5, pp. 1328
Cancers; Volume 14; Issue 5; Pages: 1328
Cancers, Vol. 14, No 5 (2022) P. 1328
Cancers; Volume 14; Issue 5; Pages: 1328
Cancers, Vol. 14, No 5 (2022) P. 1328
Background: An increase in breast cancer (BC) incidence in young women (YW) as well as disparities in BC outcomes have been reported in Switzerland. We sought to evaluate treatment and outcome differences among YW with BC (YWBC).Methods: YW diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082ca8cc348a1676a05039ae7fc723f6
https://www.zora.uzh.ch/id/eprint/227987/
https://www.zora.uzh.ch/id/eprint/227987/
Autor:
Elena Jane Mason, Alba Di Leone, Antonio Franco, Sabatino D’Archi, Chiara Rianna, Alejandro Martin Sanchez, Federica Murando, Cristina Accetta, Lorenzo Scardina, Daniela Andreina Terribile, Riccardo Masetti, Gianluca Franceschini
Publikováno v:
Cancers; Volume 14; Issue 22; Pages: 5624
Oncoplastic level II breast-conserving surgery (OPS2) allows for wider excisions than standard breast-conserving surgery, but the literature on this technique in the treatment of DCIS is scarce. This study compares OPS2 to conservative mastectomy (CM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b27f672245718667be9ce01696f86710
https://hdl.handle.net/10807/221764
https://hdl.handle.net/10807/221764
Autor:
Stefano Magno, Alessio Filippone, Cristina Accetta, Cristina Rossi, Maria Maddalena Rossi, Claudia Maggiore, Annalisa Di Micco, Luana Forcina, Gianluca Franceschini, Alba Di Leone, Riccardo Masetti, Daniela A Terribile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bcf9477822e5c9824b9195b1ada4bf6
https://hdl.handle.net/10807/221768
https://hdl.handle.net/10807/221768
Autor:
Andreina, Oliverio, Paolo, Radice, Mara, Colombo, Angelo, Paradiso, Stefania, Tommasi, Antonella, Daniele, Daniela Andreina, Terribile, Stefano, Magno, Donatella, Guarino, Siranoush, Manoukian, Bernard, Peissel, Eleonora, Bruno, Patrizia, Pasanisi
Publikováno v:
Frontiers in genetics. 13
The female carriers of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4194e82ee383c50706313816b756c14
https://pubmed.ncbi.nlm.nih.gov/35356420
https://pubmed.ncbi.nlm.nih.gov/35356420
Autor:
Alba Di Leone, Antonio Franco, Daniela Andreina Terribile, Stefano Magno, Alessandra Fabi, Alejandro Martin Sanchez, Sabatino D’Archi, Lorenzo Scardina, Maria Natale, Elena Jane Mason, Federica Murando, Fabio Marazzi, Armando Orlandi, Ida Paris, Giuseppe Visconti, Antonella Palazzo, Valeria Masiello, Liliana Barone Adesi, Marzia Salgarello, Riccardo Masetti, Gianluca Franceschini
Publikováno v:
Cancers; Volume 14; Issue 5; Pages: 1275
Oncoplastic surgery level II techniques (OPSII) are used in patients with operable breast cancer. There is no evidence regarding their safety and efficacy after neoadjuvant chemotherapy (NAC). The aim of this study was to compare the oncological and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8b8705a42824e2b06c858d4c4982b5
https://doi.org/10.3390/cancers14051275
https://doi.org/10.3390/cancers14051275